The outlook of companies tied to Sildenafil's history presents a challenging investment landscape. While the initial success generated substantial gains, generic copies have significantly diminished market share . Investing in connected pharmaceutical companies now requires a careful assessment of patent safeguards, evolving medical trends , and th